lobbying_filings_raw: 77d82931-441b-4df0-ab61-dbf17360f539

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API. Sortable columns (indexed): filing_type, client_name, filing_year, client_state, registrant_state, registrant_house_id, registrant_id. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
77d82931-441b-4df0-ab61-dbf17360f539 MM 86653 D. LYNN JOHNSON 173328 KING PHARMACEUTICALS INC 2004 mid_year 2004-06-30T00:00:00-04:00 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/77d82931-441b-4df0-ab61-dbf17360f539/", "filing_uuid": "77d82931-441b-4df0-ab61-dbf17360f539", "filing_type": "MM", "filing_type_display": "Mid-Year Report", "filing_year": 2004, "filing_period": "mid_year", "filing_period_display": "Mid-Year (Jan 1 - Jun 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/77d82931-441b-4df0-ab61-dbf17360f539/print/", "filing_document_content_type": "application/pdf", "income": "20000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": null, "dt_posted": "2004-06-30T00:00:00-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": "United States of America", "registrant_address_1": null, "registrant_address_2": null, "registrant_different_address": null, "registrant_city": null, "registrant_state": null, "registrant_zip": null, "registrant": {"id": 86653, "url": "https://lda.senate.gov/api/v1/registrants/86653/", "house_registrant_id": 36580, "name": "D. LYNN JOHNSON", "description": null, "address_1": "22 PENDLETON PLACE", "address_2": null, "address_3": null, "address_4": null, "city": "KINGSPORT", "state": "TN", "state_display": "Tennessee", "zip": "37664", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "", "contact_telephone": "", "dt_updated": "2022-01-13T14:54:24.938041-05:00"}, "client": {"id": 173328, "url": "https://lda.senate.gov/api/v1/clients/173328/", "client_id": 12, "name": "KING PHARMACEUTICALS INC", "general_description": null, "client_government_entity": null, "client_self_select": null, "state": "TN", "state_display": "Tennessee", "country": "US", "country_display": "United States of America", "ppb_state": "TN", "ppb_state_display": "Tennessee", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2003-05-13"}, "lobbying_activities": [{"general_issue_code": "TRD", "general_issue_code_display": "Trade (domestic/foreign)", "description": "Contacted members of the House and Senate to make them aware of King's concern about the importation/reimportation of drugs into the United States.", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 30450, "prefix": null, "prefix_display": null, "first_name": "D", "nickname": null, "middle_name": "LYNN", "last_name": "JOHNSON", "suffix": null, "suffix_display": null}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Contacted a member of the U.S. House to ask support for an appropriation to procure and install emergency FDA approved self-administered auto-injectors containing atropine and pralidoxime in the Washington Metropolitan Area Transit Authority Metro Rail System.", "foreign_entity_issues": null, "lobbyists": [{"lobbyist": {"id": 30450, "prefix": null, "prefix_display": null, "first_name": "D", "nickname": null, "middle_name": "LYNN", "last_name": "JOHNSON", "suffix": null, "suffix_display": null}, "covered_position": "N/A", "new": null}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} TN US 36580 TN TN US US     0         20000.0  

Links from other tables